Groupe la Francaise’s Inozyme Pharma INZY Stock Holding History

Groupe la Francaise’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-223,799	Closed	-$895K	–	803
2025 Q2	$895K	Buy	+223,799	New	+$554K	0.01%	269

Groupe la Francaise's INZY Position: Q3 2025 in Review

Groupe la Francaise sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 223,799 shares — an estimated $895K sold.

Groupe la Francaise first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $895K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Groupe la Francaise reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Groupe la Francaise sold 223,799 Inozyme Pharma shares in Q3 2025, an estimated $895K.
Groupe la Francaise first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
Groupe la Francaise's Inozyme Pharma position peaked at $895K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Groupe la Francaise's 13F filing for Q3 2025, filed 13 Nov 2025.